Biosynex SA (EPA:ALBIO)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Sale of Merchandise		42.94M	52.09M	99.36M	174.66M	109.83M
Sale of Merchandise Growth		-17.58%	-47.57%	-43.11%	59.03%	466.22%
Products Sold		24.63M	15.39M	29.86M	44.06M	13.69M
Products Sold Growth		60.00%	-48.44%	-32.25%	221.97%	0.37%
Services Sold		1.89M	2.37M	9.39M	18.58M	5.60M
Services Sold Growth		-20.40%	-74.72%	-49.48%	232.05%	367.09%
Unallocated Immobilised Production		911.00K	1.35M	672.00K	525.07K	302.06K
Unallocated Immobilised Production Growth		-32.47%	100.74%	27.98%	73.83%	12.93%
Unallocated Operating Grants		-	-	282.00K	435.83K	161.67K
Unallocated Operating Grants Growth		-	-	-35.30%	169.58%	17.64%
Total		70.36M	71.21M	139.55M	238.26M	129.57M
Total Growth		-1.19%	-48.97%	-41.43%	83.88%	274.11%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
France		52.82M	52.56M	120.20M	193.70M	109.80M
France Growth		0.50%	-56.27%	-37.95%	76.41%	337.45%
Export		48.35M	40.42M	76.40M	189.00M	44.10M
Export Growth		19.61%	-47.10%	-59.58%	328.57%	336.63%
Total		101.17M	92.98M	196.60M	382.70M	153.90M
Total Growth		8.81%	-52.71%	-48.63%	148.67%	337.22%

Source: S&P Global Market Intelligence.